Loading...
Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells
Trastuzumab has been widely used for the treatment of human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer, however, it cannot easily cross the blood-brain barrier (BBB) and is known to increase the incidence of brain metastases. In contrast, lapatinib has a low molecular wei...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5346700/ https://ncbi.nlm.nih.gov/pubmed/27738326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12597 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|